How Can We Boost Colorectal and Hepatocellular Cancer Screening Among Underserved Populations?

Melissa Goebel, Amit G. Singal, Jesse Nodora, Sheila F. Castañeda, Elena Martinez, Chyke Doubeni, Adeyinka Laiyemo, Samir Gupta

Research output: Contribution to journalReview articlepeer-review

9 Scopus citations


Colorectal cancer (CRC) and hepatocellular carcinoma (HCC) are common causes of cancer incidence and mortality in the USA, particularly among underserved populations such as racial/ethnic minorities, the under-/uninsured, and individuals with low socioeconomic status. Although screening can reduce cancer-related mortality, participation is suboptimal among underserved populations, likely serving as the largest contributor to observed inequities in HCC and CRC outcomes among US populations. In this narrative review, we highlight inequities across populations in the USA with respect to incidence and mortality for CRC and HCC and highlight potential causes, with a focus on screening rates. In addition, drawing from the recent literature, we highlight promising strategies for increasing screening for HCC and CRC and propose future research and policy solutions to optimize screening rates. With focused implementation of screening strategies and novel research, the burden of HCC and CRC can be reduced among underserved populations.

Original languageEnglish (US)
Article number22
JournalCurrent gastroenterology reports
Issue number6
StatePublished - Jun 4 2015


  • Colorectal cancer screening
  • Hepatocellular carcinoma screening
  • cancer disparities

ASJC Scopus subject areas

  • Gastroenterology


Dive into the research topics of 'How Can We Boost Colorectal and Hepatocellular Cancer Screening Among Underserved Populations?'. Together they form a unique fingerprint.

Cite this